Selected through a competitive peer-review process, the nine fellows will each receive $220,000 over two years and work under the supervision of a mentor to transition to a faculty-level position. This year's fellows include Jacob E. Lemieux (Partners HealthCare System), whose research project is focused on microbial determinants of clinical heterogeneity in Lyme disease; Esther R. Berko (Children's Hospital of Philadelphia), whose research will address the significance of subclonal driver mutations in high-risk neuroblastoma; Marguerite Indriati Hood Pishchany (Boston Children's Hospital), who will study ecology-driven vaginal microbiome interventions for reproductive health; Erin M. Parry (Dana-Farber Cancer Institute), whose research is focused on the mechanisms underlying response and resistance to the immune checkpoint blockade in Richter's Transformation; and Kate Millington (Boston Children's Hospital), who will conduct research on the effects of sex steroids on cardiovascular risk factors in transgender adolescents.
"We are excited to support these outstanding clinical researchers during a critical stage in their careers: the period between residency and early faculty called 'fellowship,'" said DDCF medical research program director Betsy Myers. "In our research into the needs of the field, clinical investigators at the early faculty stage repeatedly voiced a need for increased protected time for research and financial support beyond what is required during the fellowship phase of training. We are proud to answer that call to action and to award these nine physician scientist fellows with the resources they need to advance their careers and make important contributions to patient care."
For a complete list of this year's awardees, see the DDCF website.